Zaleska · Lymphatic research and biology 2017 · observational biomarker study · n=?

Serum Immune Proteins in Limb Lymphedema Reflecting Tissue Processes Caused by Lymph Stasis and Chronic Dermato-lymphangio-adenitis (Cellulitis).

Level 4 - case-series / case-control

Observational biomarker study without specified control group details or intervention.

PubMed 28880710 · doi:10.1089/lrb.2017.0003 · record verified 2026-08-26

What was done

Serum concentrations of specific proteins were measured in patients with limb lymphedema across three categories: markers of cellular disintegration (caspase 1, sFas, HMGB1, serpin), growth-regulating factors (cortisol, human growth hormone, keratinocyte growth factor, IGF), and angiogenic or adipose-related factors (angiopoietins 1 and 2, adiponectin, leptin, TGF-beta).

What was found

The authors reported increased concentrations of caspase 1, sFas, serpin, HMGB1, cortisol, IGF, angiopoietin 1, adiponectin, and leptin in patients without systemic clinical or biochemical signs of inflammation. The abstract reports no numerical values, effect sizes, comparator data, or p-values.

Why it matters

This indicates that lymphedema involves chronic local cellular breakdown and adipose remodeling reflected systemically in serum, rather than being solely a disorder of mobile fluid volume.

Limits

The abstract does not report sample size, control group details, numerical data, or statistical tests. The recommendation for anti-inflammatory medication is a speculative inference not tested in the study.